Cumberland Pharmaceuticals Inc. | Key People and Executives
A. J. Kazimi
Chairman & Chief Executive Officer
Martin E. Cearnal
Director, Executive VP-Marketing & Sales
Joey A. Jacobs
Lead Independent Director
Caroline R. Young
Independent Director
Gordon R. Bernard
Independent Director
James R. Jones
Independent Director
Jonathan I. Griggs
Independent Director
Kenneth John Krogulski
Independent Director
A. J. Kazimi
Chairman & Chief Executive Officer
Leo B. Pavliv
EVP-Operations & Chief Development Officer
Michael P. Bonner
CFO, Senior Director-Finance & Accounting
Adam Haeberle
Senior Director-Clinical & Regulatory Affairs
Amy Dix Rock
Senior Director-Regulatory & Scientific Affairs
James L. Herman
Chief Compliance Officer & Senior Vice President
Martin E. Cearnal
Director, Executive VP-Marketing & Sales
Cindy Patton
Senior Director-Field Sales & Marketing
Jean W. Marstiller
Secretary & Senior VP-Administrative Services
Michael Schulz
Manager-Government & Community Affairs
Joey A. Jacobs
Lead Independent Director
Caroline R. Young
Independent Director
Gordon R. Bernard
Independent Director
James R. Jones
Independent Director
Jonathan I. Griggs
Independent Director
Kenneth John Krogulski
Independent Director
| Address |
2525 West End Avenue
Nashville Tennessee 37203
United States
|
|
Employees
|
- |
| Website |
http://www.cumberlandpharma.com |
| Updated |
07/08/2019 |
| Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A. |
